CCN2 and neoplasm: After 3-day treatment at 30 mg/kg PO in immunodeficient mice bearing NCI-H226 tumors, I-27 led to >50% downregulation of CTGF mRNA in the tumor, a known transcriptional target of YAP1–TEAD.